Workflow
QuickLogic Reports Fiscal Third Quarter 2025 Financial Results
Prnewswire· 2025-11-12 05:05
Accessibility StatementSkip Navigation SAN JOSE, Calif., Nov. 11, 2025 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK) ("QuickLogic" or the "Company"), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs, and Endpoint AI solutions, today announced its financial results for the fiscal third quarter that ended September 28, 2025. Recent Highlights "We have logged significant progress during the last three months," said Brian Faith, CEO of QuickLogic. "Our investment to accelerate the fabrication o ...
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Globenewswire· 2025-11-12 05:05
SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced that on November 10, 2025, one new employee was granted an inducement award consisting of a stock option to purchase 4,881 shares of common stock. The option was granted pursuant to the Aardvark Therapeutics, Inc. 2 ...
Proficient Auto Logistics Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-11-12 05:05
JACKSONVILLE, Fla., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the “Company” or “Proficient”) today reported its financial results for the three months ended September 30, 2025. Third Quarter Summary Total Operating Revenue of $114.3 million, increased 24.9% from Q3 2024Total Operating Loss of ($0.1) million, versus ($2.2) million in Q3 2024Adjusted Operating Income(1) of $4.2 million, versus $1.1 million in Q3 2024Adjusted Operating Ratio(1) of 96.3% compared to 98.8% ...
Concrete Pumping's Brundage-Bone Subsidiary Expands International Presence with Acquisition of C.G.A. Concrete Pumping Ltd in the Republic of Ireland
Globenewswire· 2025-11-12 05:05
DENVER, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the "Company" or "CPH") wholly-owned subsidiary Brundage-Bone Concrete Pumping, Inc. (“Brundage-Bone”), a leading provider of concrete pumping services based in the U.S., has completed the acquisition of C.G.A. Concrete Pumping Ltd.(“CGA”), based in Cork, Republic of Ireland. This acquisition marks an exciting step in Brundage-Bone’s international expansion and ongoing investment strategy. CGA has built a strong reputa ...
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2025
Globenewswire· 2025-11-12 05:05
NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of October 31, 2025, short interest in 3,402 Nasdaq Global MarketSM securities totaled 14,079,841,205 shares compared with 13,834,913,159 shares in 3,382 Global Market issues reported for the prior settlement date of October 15, 2025. The October short interest represents 1.99 days compared with 2.09 days for the prior reporting period. Short interest in 1,695 securities on The Nasdaq Capital MarketSM totaled 3,185,380,810 shares ...
ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London
Globenewswire· 2025-11-12 05:05
PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference – London on Tuesday, November 18, at 3:00 p.m. GMT/10:00 a.m. ET. The live and archived fireside chat will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of th ...
LightPath Technologies Reports Fiscal 2026 First Quarter Financial Results
Prnewswire· 2025-11-12 05:05
Financial Summary: Accessibility StatementSkip Navigation ORLANDO, Fla., Nov. 11, 2025 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal first quarter ended September 30, 2025. First Quarter Fiscal 2026 & Subsequent Highlights: Management Commentary Sam Rubin, Chief Executive Officer of LightPat ...
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.
Globenewswire· 2025-11-12 05:05
Conversation Centered Around Healthcare Communications and Pandemic PreparednessLOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today announced that Chief Executive Officer, Brad Burnam, spoke with Dr. Robert Redfield, M.D., former Director of the Centers for Disease Control and Prevention (CDC) about healthcare communication and ways to restore public trust ...
Alico, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on Monday, November 24, 2025
Globenewswire· 2025-11-12 05:05
FORT MYERS, Fla., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that the Company will release financial results for the fourth quarter and full year ended September 30, 2025, on Monday, November 24, 2025 after market close. The Company will host a conference call to discuss its financial results on Tuesday, November 25, 2025, at 8:30 am Eastern Time. Interested parties may join the conference call by dialing 1-800-245-3047 in the United States and 1- ...
Iridex Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-11-12 05:05
MOUNTAIN VIEW, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the third quarter ended September 27, 2025. Third Quarter 2025 Financial Highlights Generated total revenue of $12.5 million, representing growth of 8% year-over-year compared to $11.6 million in the prior yea ...